Detalhe da pesquisa
1.
Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors.
Cancer Immunol Immunother
; 72(10): 3217-3228, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428196
2.
Treatment in patients with acute myeloid leukemia/high-risk myelodysplastic syndrome with hypomethylating agents: Day-hospital management compared to home care setting.
Eur J Haematol
; 111(2): 311-317, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37231885
3.
Dynamic Changes of Peripheral NK Cells Predict Outcome in Patients with PD-L1 Positive Non-small-cell Lung Cancer Undergoing Immune Checkpoint Inhibitors as Second-line Therapy.
Cancer Invest
; 40(8): 710-721, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35736808
4.
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.
Hematol Oncol
; 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29602219
5.
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study.
Clin Exp Med
; 24(1): 13, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244147
6.
Changes in Peripheral Immune Cells after the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine and Disease Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Prospective Analysis of the Vax-on-Third-Profile Study.
Cancers (Basel)
; 15(14)2023 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509286
7.
Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study.
Front Oncol
; 13: 1280416, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023235
8.
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs.
Cancers (Basel)
; 15(7)2023 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046720
9.
Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: Results from the Vax-On-Profile study.
Int Immunopharmacol
; 108: 108774, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461110
10.
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients.
Sci Rep
; 12(1): 21908, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535985
11.
External validation of the accuracy of 'CLLflow score'.
J Investig Med
; 66(7): e6, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30217834